“blackthorn-therapeutics” Archives

in
Entry Author Date Location
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More 12/13/19 National
Neuroscience Is Taking the Spotlight at Xconomy’s Bay Area Xchange 11/11/19 San Francisco
The Placebo Effect Is Hobbling New Psychiatric Drugs. What Can Stop It? 10/10/19 National
Bio Roundup: Roche-Spark Drags On, GSK Taps CRISPR, Diabetes News & More 06/14/19 National
Can AI Tools, $76M Lead BlackThorn to Targeted Psych Drugs? 06/13/19 San Francisco
Mindstrong Adds $15M for Tech That Predicts Mental Health Changes 06/14/18 San Francisco
Former Gates Investor, Advisor Unveil $200M Biomatics Health Fund 03/15/17 Seattle
BlackThorn Therapeutics Obtains $14,000,000 Series A Funding 01/06/17 San Francisco
Bio Roundup: Jenkins Gets Mad, Bernie Gets His Pen, CRISPR IPO & J-Lo 10/21/16 National
BlackThorn Therapeutics Garners $40,000,000 Series A Round 10/21/16 San Francisco
BlackThorn Emerges With $40M, New Weapons Against Neuro Disorders 10/20/16 San Francisco
West Coast Bio Roundup: Shkreli, BlackThorn, Unhappy Holiday Layoffs 12/24/15 San Francisco
Amid Neuroscience Renaissance, BlackThorn Quietly Builds a Business 12/23/15 San Francisco
Page 1 of 1